Latest news with #SusanWilliams
BBC News
30-05-2025
- Health
- BBC News
Chelmsford woman awarded £250k after ceiling collapse on her
A woman has been awarded £250,000 from a county council after she suffered serious injuries when the ceiling of a family centre collapsed on her. Susan Williams, from Chelmsford, was teaching in Essex in 2016, when the ceiling gave way and landed on her head. In 2021 another ceiling fell down, close to her, causing her distress. Ison Harrison, her solicitors, said the incidents led to "a long period of medical treatment and life-altering consequences". Essex County Council said: "We are very sorry for what happened to Ms Williams and accepted responsibility at a very early stage in these proceedings." The solicitors said Ms Williams had been sitting in a chair in Writtewick Family Centre, Chelmsford, in 2016, when a large section of the ceiling suddenly gave way, falling directly on to her head. The family centre practitioner had multiple injuries, including lacerations that needed stitches, concussion, neck and shoulder pain, cuts and bruises and long-term psychological trauma, the Local Democracy Reporting Service said. She was later diagnosed with post-traumatic fibromyalgia by a consultant rheumatologist, which was confirmed by pain specialists. She returned to work, initially on reduced hours, but the "symptoms persisted and significantly affected her mobility and quality of life", Ison Harrison added. Then in 2021, a section of the ceiling collapsed and "narrowly missed her" at the New Family Centre on the county hall site in Chelmsford. This retriggered Ms Williams' symptoms and "led to severe psychological distress, ultimately resulting in her being medically retired at the age of 58". The solicitors said the council "vigorously defended the case for over eight years". It added that the council eventually admitted liability for the initial incident, but denied the extent of the Williams' solicitor Diane Askwith said: "It is such a shame it took so long. "The council's behaviour has been, at the very least, disappointing — arguing at every stage, even in the face of clear medical evidence."Ms Williams was injured through no fault of her own and lost a career she loved."The council said: "When agreeing compensation, we must always make sure the compensation claimed is justified. "Unfortunately, there was a dispute about how much compensation was due."We are pleased that ultimately we were able to agree an amount of compensation which we felt was justified." Follow Essex news on BBC Sounds, Facebook, Instagram and X.
Yahoo
06-04-2025
- Business
- Yahoo
Institutional owners may consider drastic measures as W.W. Grainger, Inc.'s (NYSE:GWW) recent US$1.6b drop adds to long-term losses
Significantly high institutional ownership implies W.W. Grainger's stock price is sensitive to their trading actions A total of 16 investors have a majority stake in the company with 50% ownership Insiders have sold recently This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Every investor in W.W. Grainger, Inc. (NYSE:GWW) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 74% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk). As a result, institutional investors endured the highest losses last week after market cap fell by US$1.6b. This set of investors may especially be concerned about the current loss, which adds to a one-year loss of 6.4% for shareholders. Institutions or "liquidity providers" control large sums of money and therefore, these types of investors usually have a lot of influence over stock price movements. As a result, if the downtrend continues, institutions may face pressures to sell W.W. Grainger, which might have negative implications on individual investors. In the chart below, we zoom in on the different ownership groups of W.W. Grainger. Check out our latest analysis for W.W. Grainger Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. W.W. Grainger already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at W.W. Grainger's earnings history below. Of course, the future is what really matters. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. We note that hedge funds don't have a meaningful investment in W.W. Grainger. The Vanguard Group, Inc. is currently the company's largest shareholder with 11% of shares outstanding. With 8.3% and 7.9% of the shares outstanding respectively, BlackRock, Inc. and Susan Williams are the second and third largest shareholders. Susan Williams, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors. Looking at the shareholder registry, we can see that 50% of the ownership is controlled by the top 16 shareholders, meaning that no single shareholder has a majority interest in the ownership. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions. Our most recent data indicates that insiders own some shares in W.W. Grainger, Inc.. It is a very large company, and board members collectively own US$3.7b worth of shares (at current prices). Most would say this shows a good alignment of interests between shareholders and the board. Still, it might be worth checking if those insiders have been selling. With a 17% ownership, the general public, mostly comprising of individual investors, have some degree of sway over W.W. Grainger. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders. While it is well worth considering the different groups that own a company, there are other factors that are even more important. Be aware that W.W. Grainger is showing 1 warning sign in our investment analysis , you should know about... Ultimately the future is most important. You can access this free report on analyst forecasts for the company . NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
11-02-2025
- Health
- Yahoo
John B. Amos among first to give new cancer treatment in Georgia
Columbus, Ga (WRBL) – Columbus' John B Amos Cancer Center is now leading the way to administer a new cancer treatment in the Peach treatment is commonly known as 'BiTE' and it stands for 'Bi-Specific T-Cell Engager Therapies'. It's showing very promising results treating small-cell lung cancer, lymphoma and multiple myeloma. This treatment helps the body's immune system recognize cancer cells and then destroy them. Phenix City native, Susan Williams, the first patient to receive this treatment at the cancer was so thankful that the treatment is working well, and she can get this treatment so close to home instead of traveling hours away. 'I could not have done it. I have a daughter that takes care of me but she's also got health issues. It's just the two of us. I have to be here in town to be able to come to a local place. This is the best place that I can think of to go to,' said Williams. Susan was diagnosed with small cell carcinoma in October 2023. She learned of this diagnosis when she was on a regular checkup during an annual exam. Oncologists also believe 'BiTE' therapy can become a way more effective way of treating cancer patients. 'I and others believe this form of therapies can be an extraordinary effective. Not just for the rare illnesses but will probably come into play across a broad scope of cancers. And it will be moved up in the cancer treatment scheme,' said Dr. Andy Pippas, Chief of Medical Oncology for Piedmont Healthcare. There are currently nine BiTE therapies approved for oncology by the US Food and Drug Administration, and the John B. Amos Cancer Center will have seven of those medications available in 2025. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
